• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
THL
Click for more information
2.58% $1.89

Tourism Holdings Limited - Charts / Financials

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open $1.94   Day High $1.96   Day Low $1.89
Daily Volume 73516
Bids   Sellers
Number Price Volume   Number Price Volume
0 $1.89 17524   0 $1.95 5438

Data source: Refinitiv

(20min delay)
Last
$1.89 		Change
-0.050(2.58%) 		Mkt cap ! n/a
Open High Low Value Volume
$1.94 $1.96 $1.89 $141.7K 73.51K

Buyers (Bids)

No. Vol. Price($)
0 17524 $1.89
 

Sellers (Offers)

Price($) Vol. No.
$1.95 5438 0
Last trade - 13.00pm 22/11/2024 (20 minute delay) ?

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.